GluteGuard Canada – Clinically proven product set to transform the lives of those on a gluten free diet across Canada in partnership with Norwell Consumer Healthcare.
Glutagen, a leader in enzyme therapy research in gluten-related disorders, proudly announces the Canadian launch of GluteGuard, the world’s only clinically proven product to protect against the symptoms of accidental gluten ingestion.
Glutagen’s commitment to innovation and evidence-based clinical research speared the discovery of the unique enzyme Caricain and the consequent development of their flagship product, GluteGuard. Within just two years, GluteGuard has achieved extensive pharmacy distribution across Australia, a testament to its effectiveness and consumer demand. The product’s innovation was further recognised when it was honoured with the Outstanding & Innovative New Consumer Healthcare Product award from Consumer Health Products Australia in 2023.
Building on this success and in partnership with Norwell Healthcare, GluteGuard is now available across Canada in major retailers, including Walmart, Shoppers Drug Mart, and Rexall. The launch marks a significant milestone in Glutagen’s global expansion strategy.
“GluteGuard Canada is an exciting step in enhancing the lives of those on a gluten free diet across the world” said Ezequiel Pena, CEO of Glutagen. “The discovering of Caricain and innovation of GluteGuard has been life-changing for many here in Australia, and we are thrilled to partner with Norwell Consumer Healthcare to make it widely available now in Canada.”
Norwell Consumer Healthcare is part of the Pharmascience family of companies, which is the largest Canadian-owned pharmaceutical company, known for offering trusted, clinically proven over-the-counter solutions.
Glutagen’s partnership with Norwell ensures strong market support for GluteGuard Canada, positioning it for success with continued emphasis on education of both the consumer and the Healthcare Professional network.
“Norwell’s expertise and commitment to wellness align perfectly with our vision,” added Ezequiel “Together, we’re bringing meaningful change to the gluten free community across Canada.”
“This is just the beginning,” he continued. “We are committed to expanding the GluteGuard brand globally and enhancing the lives of those managing coeliac disease and other gluten-related disorders. Stay tuned for more developments as we continue this journey.”
About Glutagen
Glutagen, headquartered in Melbourne, Australia, specialises in developing therapeutics for gluten-related disorders. Through evidence-based innovation and enzyme therapy research, Glutagen offers high-quality products that enhance the health and lifestyle of the gluten free community. For more information, visit glutagen.com.
About Norwell Consumer Healthcare
Norwell Consumer Healthcare focuses on providing trusted, clinically proven OTC solutions to meet Canadians’ health and wellness needs. As an affiliate of the Pharmascience family, Norwell brings agility and innovation to the market. Learn more at norwellcanada.ca.
